Lifeway Foods (LWAY) Proxy Filing summary

Executive summary

• Board opposes dissident nominees, citing ethical and financial concerns, and urges shareholders to reject their proposals.

• Dissident nominees are accused of personal financial distress and actions not aligned with shareholder interests.

• Institutional Shareholder Services (ISS) recommended against voting for dissident proposals, noting lack of a compelling case for change.

• Company highlights strong financial performance, including 788% total shareholder return over five years and 123% revenue growth since FY2019.

• Forward-looking statements caution about risks and uncertainties affecting future results.

Voting matters and shareholder proposals

• Shareholders are asked to vote on board nominees, with the board urging rejection of dissident candidates.

• ISS advised shareholders not to support dissident proposals or nominees.

• Board refreshment and director nominations are key agenda items for the 2025 annual meeting.

Board of directors and corporate governance

• Recent board refreshment added four new independent directors unaffiliated with management or dissident parties.

• Long-serving directors Pol Sikar and Jason Scher will not be renominated at the 2025 and 2026 meetings, respectively.

• By 2026, the board will be controlled by new independent members.

• Board composition changes aim to increase independence and effectiveness.